First human test for new Parkinson's hope
Knowledge-focused
Completed
This early-stage study aimed to check if a new drug called PDM608 is safe for people and to see how the body handles it. The trial involved 64 healthy adults who received either the drug or a placebo as a single shot or weekly shots for a month. The main goal was to monitor for a…
Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC